Korro Bio (KRRO) Depreciation & Amortization (CF) (2018 - 2026)
Korro Bio (KRRO) posted Depreciation & Amortization (CF) of $400000.0 for Q1 2026, down 38.37% on a QoQ basis from $649000.0 in Q4 2025, and down 67.35% year-over-year from $1.2 million in Q1 2025.
Korro Bio (KRRO) Depreciation & Amortization (CF) (2018 - 2026) Analysis & Trends
Korro Bio's Depreciation & Amortization (CF) history runs 9 years deep, the most recent figure standing at $400000.0 for Q1 2026.
- Quarterly Depreciation & Amortization (CF) fell 67.35% year-over-year to $400000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.4 million (down 16.39% YoY) and the FY2025 annual result came in at $4.3 million, up 18.89% from the prior year.
- Depreciation & Amortization (CF) was $400000.0 for Q1 2026 at Korro Bio, down from $649000.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $1.3 million in Q4 2024 and bottomed at $385000.0 in Q3 2023.
- A 5-year average of $791647.1 and a median of $700000.0 in 2024 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) surged 136.21% — and 2026, when it plunged 67.35%.
- Korro Bio's Depreciation & Amortization (CF) stood at $417000.0 in 2022, then jumped by 136.21% to $985000.0 in 2023, then soared by 31.98% to $1.3 million in 2024, then sank by 50.08% to $649000.0 in 2025, then plunged by 38.37% to $400000.0 in 2026.
- Business Quant data shows KRRO's Depreciation & Amortization (CF) at $400000.0 in Q1 2026, $649000.0 in Q4 2025, and $1.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 41.14 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 2.20 Mn |
| 10 | Korro Bio | 123.70 Mn | 9.73 Mn | - | 400,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 649,000.00 |
| Dec 31, 2025 | 649,000.00 |
| Sep 30, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Dec 31, 2024 | 1.30 Mn |
| Sep 30, 2024 | 900,000.00 |
| Sep 30, 2024 | 900,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 985,000.00 |
| Dec 31, 2023 | 985,000.00 |